Digest

New Research Released by Pendulum Therapeutics

Discover Pendulum Glucose Control

Pendulum Takes The First Step Toward Predicting Whether Microbiome Bacteria Can Feed on Certain Types of Fiber

Continuous Glucose Monitors Could Modernize Clinical Trials with Remote Data Collection

Pendulum Therapeutics Announces Publication Of Clinical Data For First-Ever Medical Probiotic That Provides The Dietary Management Of A1C And Blood Glucose Levels

Pendulum Therapeutics Launches First Medical Probiotic For People With Type 2 Diabetes

Pendulum Therapeutics CEO Colleen Cutcliffe Joins American Diabetes Association Northern California Leadership Board

Pendulum Therapeutics Adds Global Health Care Executive Heather Mason to Board of Directors

Pendulum Therapeutics Announces Formation of Scientific and Medical Advisory Boards

CEO And Co-Founder Of Pendulum Therapeutics Assumes Leadership Of CLSI Board

Pendulum Therapeutics to Receive the 2019 Pantheon DiNA Rising Star Award from California Life Sciences Association

Whole Biome Announces Corporate Name Change to Pendulum Therapeutics

Whole Biome Presents Positive Clinical Data at American Diabetes Association's 79th Scientific Sessions

Whole Biome Secures $35 Million in Series B Financing for Expansion of its Microbiome Discovery Platform and Commercialization of its First Product